Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus
Top Cited Papers
Open Access
- 28 October 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 13 (1) , 137-147
- https://doi.org/10.1093/hmg/ddh021
Abstract
Relative deficiency of pentraxin proteins is implicated in the pathogenesis of systemic lupus erythematosus. The C-reactive protein (CRP) response is defective in patients with acute flares of disease, and mice with targeted deletions of the serum amyloid P component gene ( Sap ) develop a lupus-like illness. In humans, the genes for CRP ( CRP ) and SAP ( APCS ) map to 1q23.2 within an interval linked with SLE. We have investigated the candidate genes CRP and APCS in two cohorts totalling 586 UK simplex SLE families. The inheritance of an intronic dinucleotide repeat and seven single nucleotide polymorphisms in the CRP and APCS genes was examined by application of family-based tests of association and linkage. Basal levels of CRP were influenced independently by two polymorphisms at the CRP locus, CRP 2 and CRP 4. Furthermore, the latter polymorphism was linked/associated with SLE and antinuclear autoantibody production. Thus, the polymorphism associated with reduced basal CRP was also associated with the development of SLE. These data support the hypothesis that defective disposal of potentially immunogenic material is a contributory factor in lupus pathogenesis. The identification of polymorphisms that determine basal CRP levels has implications in ischaemic heart disease, where CRP level is an important predictor of risk.Keywords
This publication has 46 references indexed in Scilit:
- The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genesProceedings of the National Academy of Sciences, 2001
- Systemic Lupus Erythematosus, Complement Deficiency, and ApoptosisPublished by Elsevier ,2001
- Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: Findings in open-label and randomized placebo-controlled trialsArthritis & Rheumatism, 2000
- Anti-DNA and autoantibodiesCurrent Opinion in Rheumatology, 2000
- Comparison of Tests for Association and Linkage in Incomplete FamiliesAmerican Journal of Human Genetics, 2000
- A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair familiesProceedings of the National Academy of Sciences, 1998
- Regulation of the Human C-reactive Protein Gene in Transgenic MiceJournal of Biological Chemistry, 1995
- Dinucleotide repeat polymorphism at the CRP locusNucleic Acids Research, 1990
- Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component.Journal of Biological Chemistry, 1985
- Detection of cross‐reactive anti‐DNA antibody idiotypes in the serum of systemic lupus erythematosus patients and of their relativesArthritis & Rheumatism, 1985